{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:23:16Z","timestamp":1787772196016,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Psoriasis is a chronic, immune mediated inflammatory condition of the skin and imbalance in inflammatory mediators could result in insulin resistance, metabolic syndrome and facilitate the occurrence and progression of Non-alcoholic fatty liver disease (NAFLD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>\n                      Primary objectives:\n                      <jats:list list-type=\"arabic-numeral\">\n                        <jats:list-item>\n                          <jats:p>To study the frequency of NAFLD in cases of chronic plaque psoriasis and controls<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>To study the interleukin levels in cases of chronic plaque psoriasis and controls.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                    <jats:p>\n                      Secondary objectives:\n                      <jats:list list-type=\"arabic-numeral\">\n                        <jats:list-item>\n                          <jats:p>To study the BMI, lipid profile, waist circumference, FBS (fasting blood sugar), PPBS (post prandial blood sugar) and serum insulin in cases and controls<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>To study the association of age, duration of psoriasis, PASI (psoriasis area severity index), BSA (body surface area) involved, BMI (body mass index), lipid profile, obesity, waist circumference, FBS (fasting blood sugar), PPBS (post prandial blood sugar) and serum insulin levels with NAFLD in patients of chronic plaque psoriasis<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>To correlate serum levels of IL1-\u03b2, IL6 and TNF-\u03b1 with NAFLD in patients of chronic plaque psoriasis.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>50 clinically diagnosed cases of chronic plaque psoriasis with age \u2265 18years, diseases duration \u2265 6 months and 30 age and sex matched controls were recruited. PASI, BSA of cases was calculated and BMI, BP, WC of all subjects was measured. Serum lipid profile, FBS, PPBS, insulin level, IL1- \u03b2, IL6, TNF- \u03b1, high frequency B-mode ultrasound, LFT and fibroscan were done in all subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>28(56.0%) cases and 2(6.6%) controls had NAFLD with statistically significant difference. Significantly elevated WC, serum insulin, deranged lipid profile, fatty liver, transaminitis, fibroscan score, liver fibrosis, NAFLD and interleukins were found in cases vs controls. There was a significant association of NAFLD in psoriatic patients with increasing duration of psoriasis, BMI \u226523 Kg\/m2, high WC, increasing BSA involved, deranged lipid profile, raised total cholesterol levels and increasing number of risk factors. Nonsignificant but positive association of NAFLD in cases was found with high levels of IL1 \u2013 \u03b2, IL \u2013 6, TNF-\u03b1, FBS and increasing PASI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Significantly increased interleukin levels and their weak positive correlation with the severity of psoriasis (PASI, BSA) in patients of chronic plaque psoriasis explains the possible role of inflammation in the causation of psoriasis. Screening may be considered in psoriatic patients with increasing duration of psoriasis, high WC, high BSA involved, high BMI, obesity, dyslipidemia and insulin resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>Small sample size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conflict of Intrest:<\/jats:title>\n                    <jats:p>NONE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_1015_22","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T02:26:16Z","timestamp":1715739976000},"page":"377-384","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study"],"prefix":"10.4103","volume":"68","author":[{"given":"Vidya","family":"Yadav","sequence":"first","affiliation":[{"name":"From the Department of Dermatology and STD, Lady Hardinge Medical College and Sucheta Kriplani Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhu","family":"Mendiratta","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology and STD, Lady Hardinge Medical College and Sucheta Kriplani Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lady Hardinge Medical College and Sucheta Kriplani Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Bisherwal","sequence":"additional","affiliation":[{"name":"Department of Dermatology and STD, University College of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Lady Hardinge Medical College and Sucheta Kriplani Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Meena","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology and STD, Lady Hardinge Medical College and Sucheta Kriplani Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1468-3083.2001.00192.x","article-title":"The prevalence of psoriasis in the world","volume":"15","author":"Raychaudhuri","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjd.16239","article-title":"Nonalcoholic fatty liver disease in patients with psoriasis: A consequence of systemic inflammatory burden?","volume":"179","author":"Prussick","year":"2018","journal-title":"Br J Dermatol"},{"key":"R5-20240829","year":"2016","journal-title":"Centers for Disease Control and Prevention (CDC) Facts Sheets: Moderate Drinking"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/sj.ijo.0803111","article-title":"Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity","volume":"30","author":"Misra","year":"2006","journal-title":"Int J Obes"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4103\/2230-8210.122606","article-title":"Imaging of nonalcoholic fatty liver disease: A road less travelled","volume":"17","author":"Singh","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"R9-20240829","first-page":"33","article-title":"A Case-control study to evaluate the prevalence of nonalcoholic fatty liver disease among patients with moderate-to-severe psoriasis","volume":"11","author":"Awosika","year":"2018","journal-title":"J Clin Aesthetic Dermatol"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.86.16.6367","article-title":"Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes","volume":"86","author":"Grossman","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5114\/ada.2018.77665","article-title":"The level of proinflammatory cytokines: Interleukins 12, 23, 17 and tumor necrosis factor \u03b1 in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis","volume":"35","author":"Pirowska","year":"2018","journal-title":"Adv Dermatol Allergol"},{"key":"R12-20240829","first-page":"263","article-title":"Relationship between psoriasis and non-alcoholic fatty liver disease","volume":"11","author":"Narayanasamy","year":"2016","journal-title":"Przeglad Gastroenterol"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-0960.2012.00905.x","article-title":"The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: A study from South India","volume":"53","author":"Madanagobalane","year":"2012","journal-title":"Australas J Dermatol"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","article-title":"Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Gisondi","year":"2009","journal-title":"J Hepatol"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","article-title":"Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Miele","year":"2009","journal-title":"J Hepatol"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2013.10.044","article-title":"Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study","volume":"70","author":"van der Voort","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/ced.12672","article-title":"Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease","volume":"40","author":"Abedini","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/apt.13042","article-title":"The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic","volume":"41","author":"Roberts","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"819149","DOI":"10.1155\/2015\/819149","article-title":"IL-17A, IL-22, IL-6, and IL-21 serum levels in plaque-type psoriasis in Brazilian patients","volume":"2015","author":"de Oliveira","year":"2015","journal-title":"Mediators Inflamm"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"7963972","DOI":"10.1155\/2016\/7963972","article-title":"Liver stiffness measurement in psoriasis: Do metabolic or disease factors play the important role?","volume":"2016","author":"Pongpit","year":"2016","journal-title":"Biomed Res Int"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1015_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:32:50Z","timestamp":1787769170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1015_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_1015_22","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2022-12-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}